Miraca To Buy US Clinical Lab Testing Co. For $725M
Japan-based Miraca Holdings Inc. on Thursday announced plans to buy a unit of U.S. diagnostics provider Caris Life Sciences for $725 million in a bid to tap into the growing U.S....To view the full article, register now.
Already a subscriber? Click here to view full article